Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C, Tiseo M, Lagrasta C, Nizzoli R, Guazzi A, Leonardi F, Gasparro D, Spiritelli E, Rusca M, Carbognani P, Majori M, Franciosi V, Rindi G, Ardizzoni A. Bozzetti C, et al. Among authors: lagrasta c. J Thorac Oncol. 2008 Jan;3(1):18-22. doi: 10.1097/JTO.0b013e31815e8ba2. J Thorac Oncol. 2008. PMID: 18166836 Free article.
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity.
Bozzetti C, Musolino A, Camisa R, Bisagni G, Flora M, Bassano C, Martella E, Lagrasta C, Nizzoli R, Personeni N, Leonardi F, Cocconi G, Ardizzoni A. Bozzetti C, et al. Among authors: lagrasta c. Am J Clin Oncol. 2006 Apr;29(2):171-7. doi: 10.1097/01.coc.0000204405.96572.f9. Am J Clin Oncol. 2006. PMID: 16601438
p73 and p53 pathway in human breast cancers.
Bozzetti C, Nizzoli R, Musolino A, Martella EM, Crafa P, Lagrasta CA, Camisa R, Bonati A, Lunghi P, Ardizzoni A. Bozzetti C, et al. Among authors: lagrasta ca. J Clin Oncol. 2007 Apr 10;25(11):1451-3; author reply 1453-4. doi: 10.1200/JCO.2006.09.2023. J Clin Oncol. 2007. PMID: 17416871 No abstract available.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Loprevite M, Tiseo M, Chiaramondia M, Capelletti M, Bozzetti C, Bortesi B, Naldi N, Nizzoli R, Dadati P, Kunkl A, Zennaro D, Lagrasta C, Campanini N, Spiritelli E, Camisa R, Grossi F, Rindi G, Franciosi V, Ardizzoni A. Loprevite M, et al. Among authors: lagrasta c. Clin Cancer Res. 2007 Nov 1;13(21):6518-26. doi: 10.1158/1078-0432.CCR-07-0805. Clin Cancer Res. 2007. PMID: 17975165
Genetic alterations in combined neuroendocrine neoplasms of the lung.
D'Adda T, Pelosi G, Lagrasta C, Azzoni C, Bottarelli L, Pizzi S, Troisi I, Rindi G, Bordi C. D'Adda T, et al. Among authors: lagrasta c. Mod Pathol. 2008 Apr;21(4):414-22. doi: 10.1038/modpathol.3801014. Epub 2008 Jan 18. Mod Pathol. 2008. PMID: 18204434 Free article.
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.
Tiseo M, Rossi G, Capelletti M, Sartori G, Spiritelli E, Marchioni A, Bozzetti C, De Palma G, Lagrasta C, Campanini N, Camisa R, Boni L, Franciosi V, Rindi G, Ardizzoni A. Tiseo M, et al. Among authors: lagrasta c. Lung Cancer. 2010 Mar;67(3):355-60. doi: 10.1016/j.lungcan.2009.04.021. Epub 2009 May 26. Lung Cancer. 2010. PMID: 19473722
PTEN status in advanced colorectal cancer treated with cetuximab.
Negri FV, Bozzetti C, Lagrasta CA, Crafa P, Bonasoni MP, Camisa R, Pedrazzi G, Ardizzoni A. Negri FV, et al. Among authors: lagrasta ca. Br J Cancer. 2010 Jan 5;102(1):162-4. doi: 10.1038/sj.bjc.6605471. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953097 Free PMC article.
110 results